Search Within

Bo Dupont

  1. "Neuroblastoma Service"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (6)
  3. GSK Faculty (6)
  4. Neuroblastoma Service (6)
  5. Pediatrics, Department of (6)
  6. Tow Center for Developmental Oncology (TCDO) (6)

More Groups

People
  1. Nai-Kong Cheung (6)
  2. Jeffrey Venstrom (5)
  3. Junting Zheng (5)
  4. Katharine Hsu (5)
  5. Irene Cheung (4)
  6. Karen Danis (3)

More People

Years
  1. 2012 (1)
  2. 2011 (1)
  3. 2010 (1)
  4. 2009 (1)
  5. 2008 (1)
  6. 1998 (1)
Publications
  1. Blood (2)
  2. Cancer Research (1)
  3. Clinical Cancer Research (1)
  4. Journal of Clinical Investigation (1)
  5. Pediatric Blood and Cancer (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Hematology (2)
  3. American Society for Clinical Investigation (1)
  4. Wiley Periodicals, Inc (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
    Journal Article

    Tarek, N.; Luduec, J. B. L.; Gallagher, M. M.; Zheng, J.; Venstrom, J. M.; Chamberlain, E.; Modak, S.; Heller, G.; Dupont, B.; Cheung, N. K. V.; more...
    Journal of Clinical Investigation (2012)

    Fulltext@MSK | Save
  • KIR/HLA genotypes predictive of missing KIR ligands are associated with improved outcome in patients with high-risk neuroblastoma treated with anti-GD2 monoclonal antibody therapy
    Meeting Abstract

    Gallagher, M.; Tarek, N.; Zheng, J. T.; Venstrom, J. M.; Cheung, I. Y.; Modak, S.; Dupont, B.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving anti-GD2 monoclonal antibody 3F8
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Kushner, B. H.; Modak, S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma
    Journal Article

    Venstrom, J. M.; Zheng, J.; Noor, N.; Danis, K. E.; Yeh, A. W.; Cheung, I. Y.; Dupont, B.; O'Reilly, R. J.; Cheung, N. K. V.; Hsu, K. C.
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • Lack of HLA class I ligands for autologous inhibitory KIR is associated with improved survival following autologous stem cell transplant for children with neuroblastoma
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Hasan, R. S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Blood (2008)

    Fulltext@MSK | Save
  • Identification and characterization of autologous natural killer cell clones with anti-tumor reactivity in childhood stage 4 neuroblastoma
    Meeting Abstract

    Vyas, Y.; Selvakumar, A.; Cheung, N. K. V.; Dupont, B.
    Blood (1998)

    Fulltext@MSK | Save